Novel bivalent BET inhibitor N2817 exhibits potent anticancer activity and inhibits TAF1
Author:
Qian Wu,Dan-Qi Chen,Lin Sun,Xia-Juan Huan,Xu-Bin Bao,Chang-Qing Tian,Jianping Hu,Kai-Kai Lv,Ying-Qing Wang,Bing Xiong,Ze-Hong Miao
Publication:
Biochemical Pharmacology
© 2021 Elsevier Inc. All rights reserved.